Investing.com - Quest Diagnostics (NYSE:DGX) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Quest Diagnostics announced earnings per share of $4.48 on revenue of $3.00B. Analysts polled by Investing.com anticipated EPS of $3.98 on revenue of $2.88B.
Quest Diagnostics shares are up 11.33% from the beginning of the year, still down 5.70% from its 52 week high of $134.57 set on February 1. They are outperforming the S&P 500 which is up 1.97% from the start of the year.
Quest Diagnostics follows other major Healthcare sector earnings this month
Quest Diagnostics's report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.
Abbott Labs had beat expectations on January 27 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar